Shopping Cart
- Remove All
- Your shopping cart is currently empty
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $39 | In Stock | |
10 mg | $67 | In Stock | |
25 mg | $138 | In Stock | |
50 mg | $222 | In Stock | |
100 mg | $328 | In Stock | |
1 mL x 10 mM (in DMSO) | $43 | In Stock |
Description | AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research. |
Targets&IC50 | Amidase:13 nM |
In vitro | AM 374 (0-9 nM) inhibits anandamide degradation in N18TG2 cells. [1] |
In vivo | AM 374 (20 μg ; intraventricular injection, once) has no effect on lever pressing in FR5, but when used in combination with anandamide (intraperitoneal injection), it reduces lever pressing.[2] |
Alias | Hexadecanesulfonyl fluoride, HDSF |
Molecular Weight | 308.5 |
Formula | C16H33FO2S |
Cas No. | 86855-26-7 |
Smiles | CCCCCCCCCCCCCCCCS(F)(=O)=O |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90.0 mg/mL (291.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.